KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) EBITDA (2016 - 2025)

CareDx (CDNA) has disclosed EBITDA for 13 consecutive years, with -$6.0 million as the latest value for Q4 2025.

  • Quarterly EBITDA fell 107.16% to -$6.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$30.8 million through Dec 2025, down 175.51% year-over-year, with the annual reading at -$30.8 million for FY2025, 175.51% down from the prior year.
  • EBITDA hit -$6.0 million in Q4 2025 for CareDx, down from -$246000.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $84.4 million in Q4 2024 to a low of -$122.6 million in Q4 2023.
  • Historically, EBITDA has averaged -$15.0 million across 5 years, with a median of -$14.6 million in 2021.
  • Biggest five-year swings in EBITDA: crashed 2120.63% in 2022 and later soared 168.81% in 2024.
  • Year by year, EBITDA stood at -$15.4 million in 2021, then fell by 24.16% to -$19.1 million in 2022, then tumbled by 541.38% to -$122.6 million in 2023, then soared by 168.81% to $84.4 million in 2024, then tumbled by 107.16% to -$6.0 million in 2025.
  • Business Quant data shows EBITDA for CDNA at -$6.0 million in Q4 2025, -$246000.0 in Q3 2025, and -$11.1 million in Q2 2025.